[go: up one dir, main page]

WO2003010327A3 - Nouvelles proteines et acides nucleiques les codant - Google Patents

Nouvelles proteines et acides nucleiques les codant Download PDF

Info

Publication number
WO2003010327A3
WO2003010327A3 PCT/US2002/014199 US0214199W WO03010327A3 WO 2003010327 A3 WO2003010327 A3 WO 2003010327A3 US 0214199 W US0214199 W US 0214199W WO 03010327 A3 WO03010327 A3 WO 03010327A3
Authority
WO
WIPO (PCT)
Prior art keywords
small molecule
molecule target
nucleic acids
polynucleotide
acids encoding
Prior art date
Application number
PCT/US2002/014199
Other languages
English (en)
Other versions
WO2003010327A2 (fr
Inventor
Charles E Miller
Original Assignee
Curagen Corp
Charles E Miller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Charles E Miller filed Critical Curagen Corp
Priority to AU2002316064A priority Critical patent/AU2002316064A1/en
Publication of WO2003010327A2 publication Critical patent/WO2003010327A2/fr
Publication of WO2003010327A3 publication Critical patent/WO2003010327A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne de nouveaux polynucléotides isolés et des polypeptides cibles de petites molécules codés par lesdits polynucléotides. L'invention concerne également des anticorps qui se lient de manière immunospécifique à un nouveau polypeptide cible de petites molécules ou tout dérivé, variant, mutant ou fragment desdits polypeptide, polynucléotide ou anticorps, ainsi que des méthodes consistant à utiliser le polypeptide cible de petites molécules, le polynucléotide et l'anticorps pour la détection et le traitement d'un large éventail d'états pathologiques. Plus particulièrement, la présente invention concerne des méthodes consistant à utiliser des protéines exprimées par recombinaison et/ou de manière endogène dans divers procédés de criblage, afin d'identifier des anticorps thérapeutiques et des petites molécules thérapeutiques associés à des maladies.
PCT/US2002/014199 2001-02-21 2002-05-02 Nouvelles proteines et acides nucleiques les codant WO2003010327A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002316064A AU2002316064A1 (en) 2001-05-02 2002-05-02 Novel proteins and nucleic acids encoding same

Applications Claiming Priority (59)

Application Number Priority Date Filing Date Title
US35924501P 2001-02-21 2001-02-21
US28806301P 2001-05-02 2001-05-02
US60/288,063 2001-05-02
US28839501P 2001-05-03 2001-05-03
US60/288,395 2001-05-03
US28908701P 2001-05-07 2001-05-07
US60/289,087 2001-05-07
US28981701P 2001-05-09 2001-05-09
US28981801P 2001-05-09 2001-05-09
US60/289,817 2001-05-09
US60/289,818 2001-05-09
US29019401P 2001-05-11 2001-05-11
US60/290,194 2001-05-11
US29075301P 2001-05-14 2001-05-14
US60/290,753 2001-05-14
US29118101P 2001-05-15 2001-05-15
US60/291,181 2001-05-15
US29124301P 2001-05-16 2001-05-16
US60/291,243 2001-05-16
US29220101P 2001-05-18 2001-05-18
US60/292,001 2001-05-18
US29237401P 2001-05-21 2001-05-21
US60/292,374 2001-05-21
US29258701P 2001-05-22 2001-05-22
US60/292,587 2001-05-22
US29310701P 2001-05-23 2001-05-23
US60/293,107 2001-05-23
US29374701P 2001-05-25 2001-05-25
US60/293,747 2001-05-25
US29410901P 2001-05-29 2001-05-29
US29411001P 2001-05-29 2001-05-29
US60/294,109 2001-05-29
US60/294,110 2001-05-29
US29443401P 2001-05-30 2001-05-30
US60/294,434 2001-05-30
US29482701P 2001-05-31 2001-05-31
US60/294,827 2001-05-31
US30487901P 2001-07-12 2001-07-12
US60/304,879 2001-07-12
US30890101P 2001-07-31 2001-07-31
US60/308,901 2001-07-31
US31227001P 2001-08-14 2001-08-14
US60/312,270 2001-08-14
US31341601P 2001-08-17 2001-08-17
US60/313,416 2001-08-17
US31846301P 2001-09-10 2001-09-10
US60/318,463 2001-09-10
US32568301P 2001-09-27 2001-09-27
US60/325,683 2001-09-27
US33029201P 2001-10-18 2001-10-18
US60/330,292 2001-10-18
US33387301P 2001-11-28 2001-11-28
US60/333,873 2001-11-28
US33690901P 2001-12-03 2001-12-03
US33755201P 2001-12-03 2001-12-03
US60/336,909 2001-12-03
US60/337,552 2001-12-03
US60/359,245 2002-02-21
US10/136,826 2002-05-01

Publications (2)

Publication Number Publication Date
WO2003010327A2 WO2003010327A2 (fr) 2003-02-06
WO2003010327A3 true WO2003010327A3 (fr) 2003-12-24

Family

ID=27586854

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/014199 WO2003010327A2 (fr) 2001-02-21 2002-05-02 Nouvelles proteines et acides nucleiques les codant

Country Status (1)

Country Link
WO (1) WO2003010327A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153678B2 (en) 2000-12-20 2006-12-26 Bristol-Myers Squibb Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
CA2443147A1 (fr) 2001-04-10 2002-10-24 Agensys, Inc. Acide nucleique et proteine correspondante intitulee 184p1e2, utilises dans le traitement et la detection de cancers
CA2445781A1 (fr) * 2001-05-03 2002-11-14 Akzo Nobel N.V. Peptidylarginine deiminase 6
WO2004050007A2 (fr) * 2002-11-29 2004-06-17 Develogen Ag Proteines bt-42 mammaliennes impliquees dans la regulation de l'homeostasie energetique
WO2005051988A2 (fr) * 2003-03-03 2005-06-09 Genentech, Inc. Compositions et procedes permettant de traiter un lupus erythemateux systemique
US7608579B2 (en) 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US7553810B2 (en) 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7468350B2 (en) 2004-06-16 2008-12-23 Pneumrx, Inc. Glue composition for lung volume reduction
CA2570261C (fr) 2004-07-08 2014-06-10 Pneumrx, Inc. Dispositif, procede et materiau pour le traitement d'epanchement pleural
GB201001444D0 (en) * 2010-01-29 2010-03-17 Cambridge Entpr Ltd Biomarkers
GB201504502D0 (en) * 2015-03-17 2015-04-29 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
KR20240151873A (ko) 2015-03-17 2024-10-18 이매틱스 바이오테크놀로지스 게엠베하 췌장암 및 기타 암에 대한 면역요법에서의 사용을 위한 펩티드 및 펩티드의 조합
GB201510771D0 (en) 2015-06-19 2015-08-05 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
CA2989483A1 (fr) 2015-06-19 2016-12-22 Immatics Biotechnologies Gmbh Peptides et combinaison de peptides a utiliser dans l'immunotherapie et methodes de generation d'echafaudages a utiliser contre le cancer du pancreas et d'autres cancers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHOU C.F. ET AL.: "Identification of a keratin-associated protein that localizes to a membrane compartment", BIOCHEM. J., vol. 298, no. 2, January 1994 (1994-01-01), pages 457 - 463 *
DATABASE GENBANK [online] US NATIONAL LIBRARY OF MEDICINE, (BETHESDA, MD, USA); May 2000 (2000-05-01), BIRREN ET AL., XP002969836, Database accession no. (AC025904) *
LIAO J. ET AL.: "Association of glucose-regulated protein (grp78) with human keratin 8", FEBS LETT., vol. 417, no. 3, January 1997 (1997-01-01), pages 316 - 320, XP004261474 *

Also Published As

Publication number Publication date
WO2003010327A2 (fr) 2003-02-06

Similar Documents

Publication Publication Date Title
WO2003000842A3 (fr) Nouvelles proteines et acides nucleiques codant pour de telles proteines
WO2002081498A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2003010327A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2003040325A3 (fr) Nouvelles proteines et acides nucleiques codant ces proteines
WO2001036645A3 (fr) Nouveaux polypeptides et acides nucleiques codant les memes
WO2002072757A3 (fr) Proteines et acides nucleiques codant pour ces proteines
WO2000053742A3 (fr) Polynucleotides et proteines codees par ceux-ci
WO2001049729A3 (fr) Nouveaux polypeptides et acides nucleiques codant ceux-ci
WO2003083046A3 (fr) Nouvelles proteines et acides nucleiques codant pour de telles proteines
WO2003023001A3 (fr) Nouvelles proteines et acides nucleiques codant ces proteines
WO2003029424A3 (fr) Nouvelle proteines et acides nucleiques codant celles-ci
WO2003064628A3 (fr) Mandrin a vide faisant intervenir un materiau fritte et procede de fabrication
WO2001074856A3 (fr) Polypeptides de type wnt-7b et acides nucleiques codant pour ceux-ci
WO2003102159A3 (fr) Nouvelles proteines et nouveaux acides nucleiques codant pour ces proteines
WO2002002625A3 (fr) Nouveaux facteurs de croissance des fibroblastes et acides nucleiques codant pour ces memes facteurs
WO2003025147A3 (fr) Nouveaux polynucleotides et proteines codees par ceux-ci
WO2001062928A3 (fr) Polypeptides et acides nucleiques codant pour
WO2001070978A3 (fr) Nouveaux polypeptides et acides nucleiques codant ces polypeptides
WO2000061754A3 (fr) Nouvelles proteines humaines et polypeptides codant pour ces proteines
WO2001061009A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2001044473A3 (fr) Polypeptides et acides nucleiques codant pour ces polypeptides
WO2004048512A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2001036638A8 (fr) Nouveaux polypeptides et acides nucleiques codant pour ces polypeptides
WO2003057854A3 (fr) Nouvelles proteines et acides nucleiques codant ces dernieres
WO2003076642A3 (fr) Nouvelles proteines et acides nucleiques codant ces proteines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US US US US US US

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE CH CY DE DK FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP